Jerald Korn

General Counsel, Kaleido Biosciences, Inc.

Companies

Epizyme, Inc.Chief operating officer Mar 21, 2022 to Aug 16, 2022¹
Kaleido Biosciences, Inc.Chief operating officer Jan 18, 2022 to Mar 2, 2022²
Kaleido Biosciences, Inc.General counsel Jul 23, 2019 to Mar 2, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kaleido Biosciences, Inc.4,517 shares⁴Feb 28, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 28, 2022Shares withheld for tax 2,046 shares at $1.49 of Kaleido Biosciences, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREpizyme, Inc., Chief operating officer
2
SEC EDGARKaleido Biosciences, Inc., Chief operating officer
3
SEC EDGARKaleido Biosciences, Inc., General counsel
4
SEC EDGARKaleido Biosciences, Inc. shares after the filing of Feb 28, 2022